Symbiosis Appoints Angelika Rublack as Senior Business Development Manager
CMO Symbiosis has appointed Angelika Rublack as Senior Business Development Manager to support its expanding global client base and drive growth across several territories.
People
Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Bristol Myers Squibb Appoints EVP and Announces Major US Investment
Bristol Myers Squibb appoints Cari Gallman as EVP and invests $40 billion in the US over 5 years.
Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Asahi Kasei: Ken Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector
Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, to succeed Richard Packer as Head of Healthcare.
Suanfarma Appoints Pere Mañé as New CEO
CDMO Suanfarma appoints Pere Mañé Godina as its new CEO, marking the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.
Boehringer Ingelheim Leadership Changes
Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors.
Oncodesign Services Appoints Aidan Synnott as CEO
Oncodesign Services has appointed Aidan Synnott as chief executive officer to help strengthen its position as a trusted partner in drug discovery.
Veranova Appoints Scott Zugel as New Global VP
Veranova welcomes Scott Zugel as Global VP of Analytical Research Development Operations.
DE&I Cuts: What’s at Stake for the Chemical Industry?
Diversity, equity, and inclusion (DE&I) initiatives have become increasingly important for attracting diverse perspectives, improving problem solving and advancing innovation in companies.
Air Products Appoints Eduardo F. Menezes CEO
Air Products recently announced the appointment of Eduardo F. Menezes as Chief Executive Officer (CEO) of Air Products effective February 7, 2025, succeeding Seifollah (“Seifi”) Ghasemi, who is leaving the Company after more than 10 years of dedicated service.
Eurocolour Elects New Presidential Board
Eurocolour, the European umbrella organization for manufacturers of pigments, dyes, fillers, and ceramic decoration products, welcomes four new members to its Presidential Board.
Julie Kim to Succeed Christophe Weber as CEO of Takeda
Takeda has appointed Julie Kim, currently president of the company’s US business unit, to succeed Christophe Weber as CEO in June 2026, who will retire after 12 years in this role.
Alastair Sanderson Appointed COO at Chemical Business Association
The Chemical Business Association (CBA) has appointed Alastair Sanderson as Chief Operating Officer (COO).
Alcami Announces CEO Transition
Alcami, a contract development and manufacturing organization (CDMO), recently announced the resignation of its CEO, Bill Humphries. Alcami’s Board Chair and former CEO Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations.
Barentz Appoints Derk Jan Terhorst as CEO
Global specialty ingredients solution provider Barentz has appointed Derk Jan Terhorst as group CEO, effective Jan. 1, 2025. He will take over from Terry Hill who served as interim CEO since May 2024.
Dow Appoints Karen S. Carter as Chief Operating Officer
Dow recently announced that Karen S. Carter, currently president of Dow Packaging & Specialty Plastics, has been appointed to the role of Chief Operating Officer, effective immediately.
CEFIC Re-elects Ilham Kadri as President
Ilham Kadri, CEO of Syensqo, has been re-elected as president of CEFIC, the European Chemical Industry Council, for a two-year term, effective immediately.
Secarna Appoints Konstantin Petropoulos as CEO
Germany’s Secarna Pharmaceuticals has appointed Konstantin Petropoulos as CEO. He is stepping up from his previous role as the company’s chief business officer (CBO) and succeeds Alexander Gebauer, who is stepping down with immediate effect to focus his efforts on another company, Galimedix Therapeutics, that he has co-founded and is leading.
Barentz Appoints Lars Schneider as New CEO for EMEA
Barentz recently appointed Lars Schneider as the new Chief Executive Officer for the EMEA region, starting October 1st, 2024. Lars will also become a member of the Barentz Board.
Terremoto Biosciences Appoints Charles Baum as CEO
US biotechnology company Terremoto Biosciences has appointed Charles Baum CEO. He succeeds Peter Thompson, who will continue to serve as Terremoto’s board chairperson.
Veranova Appoints Cécile Maupas as Senior Vice President, Chief Commercial Officer
Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.
Actylis Appoints Scott Thomson as CEO
Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets formed in 2022, appointed Scott Thomson as new Chief Executive Officer.
Neste Appoints Heikki Malinen as President and CEO
Neste has appointed Heikki Malinen as president and CEO of Neste, effective Nov. 2, 2024, at the latest. He succeeds Matti Lehmus, who decided to leave the company. Malinen is currently a member of Neste’s board of directors, but will step down before taking up his new role.
Syensqo CEO Ilham Kadri Becomes CEFIC President
Ilham Kadri, CEO of Syensqo, takes on the role as president of the European Chemical Industry Council (CEFIC), succeeding Martin Brudermueller, effective today.
Wolfgang Wienand to Join Lonza as New CEO
Lonza has appointed Wolfgang Wienand as its new CEO. He will join the company during the summer of 2024 and succeed Albert M. Baehny, who took on the additional responsibility of interim CEO in October 2023 while the search for a permanent CEO took place.
Chemours Names Denise Dignam Permanent CEO
US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.
Sasol Appoints Antje Gerber as New Chemicals EVP
Sasol has appointed Antje Gerber as executive vice president Chemicals and member of the group executive committee, effective April 15, 2024. She will succeed Brad Griffith, who is to retire on June 30, 2024.
Unilever Appoints Heiko Schipper as President of Nutrition Business
Unilever has appointed Heiko Schipper as President of the group’s Nutrition business, effective May 1, 2024.
Siegfried Announces Changes in Senior Management Team
Siegfried has appointed Marianne Späne, currently chief business officer Drug Products, as chief business officer with responsibility for both the Drug Substances and Drug Products divisions of the Swiss contract manufacturing and development organization (CDMO), effective Feb. 1, 2024. Christian Dowdeswell, who previously led the Drug Substance business, has decided to leave Siegfried.
Veranova Appoints Chris Holmes as Vice President, Global Engineering
Veranova has appointed Chris Holmes as the company’s first vice president, Global Engineering. He will lead Veranova’s global engineering team in the planning, design, and execution of the company’s capital investment initiatives and lead strategic capital projects.
Natasha De Lange Appointed as Managing Director of IMCD South Africa
IMCD has appointed Natasha De Lange as managing director for South Africa, effective Feb. 1, 2024. She will be replacing Ryan Harrison, who will become managing director of Australia and New Zealand.
Murray Auchincloss Appointed as Permanent CEO of BP
BP has appointed Murray Auchincloss as its permanent CEO, effective immediately. He has been interim CEO since September 2023 after the sudden resignation of his predecessor Bernard Looney.
IFF Appoints J. Erik Fyrwald as Next CEO
International Flavors & Fragrances (IFF) has appointed J. Erik Fyrwald as next CEO and member of the company’s board of directors, effective Feb. 6, 2024. He will succeed Frank Clyburn, who will remain with the IFF until the end of March and will continue to work in an advisory capacity until December 2024.
